Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC Brain Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05241873
What this trial is testing

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Who this might be right for
Lung Neoplasm MalignantCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+17 more
Blueprint Medicines Corporation 103
Testing effectiveness (Phase 2)Study completedNCT00171834
What this trial is testing

Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 89
Early research (Phase 1)Active Not RecruitingNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 148
Testing effectiveness (Phase 2)Ended earlyNCT00554775
What this trial is testing

WBRT & Erlotinib in Advanced NSCLC and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
University College, London 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083687
What this trial is testing

Lorlatinib in ROS1+ NSCLC With Brain Metastasis

Who this might be right for
Lung Cancer (NSCLC)
Hunan Cancer Hospital 21
Testing effectiveness (Phase 2)Looking for participantsNCT05987644
What this trial is testing

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

Who this might be right for
Lung CancerNSCLCBrain Metastases
Joshua Palmer 56
Post-approval studies (Phase 4)UnknownNCT01926171
What this trial is testing

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small-cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 80
Not applicableUnknownNCT04778800
What this trial is testing

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Who this might be right for
NSCLCBrain MetastasesLeptomeningeal Metastasis
Henan Cancer Hospital 60
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Post-approval studies (Phase 4)Active Not RecruitingNCT06282874
What this trial is testing

Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

Who this might be right for
Carcinoma, Non-Small-Cell LungBrain MetastasesLeptomeningeal Metastasis
Guangdong Association of Clinical Trials 41
Early research (Phase 1)Study completedNCT03463525
What this trial is testing

Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 4
Testing effectiveness (Phase 2)WithdrawnNCT06676917
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
MedSIR
Not applicableUnknownNCT04787185
What this trial is testing

Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain Metastases

Who this might be right for
Brain Metastases From NSCLC
Azienda Ospedaliero-Universitaria Careggi 50
Large-scale testing (Phase 3)UnknownNCT04058704
What this trial is testing

Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 296
Testing effectiveness (Phase 2)Study completedNCT01516983
What this trial is testing

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Who this might be right for
Non-small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789912
What this trial is testing

BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies

Who this might be right for
Leptomeningeal MetastasisBreast CancerLung Cancer (NSCLC)
University of Miami 40
Not applicableUnknownNCT06410040
What this trial is testing

A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis

Who this might be right for
ALK-positive Non-small Cell Lung CancerBrain MetastasesMeningeal Metastasis
Sichuan Cancer Hospital and Research Institute 28
Testing effectiveness (Phase 2)UnknownNCT03614065
What this trial is testing

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Testing effectiveness (Phase 2)Study completedNCT00508144
What this trial is testing

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)UnknownNCT04643847
What this trial is testing

A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases

Who this might be right for
EGFR Positive Non-small Cell Lung CancerBrain Metastases
First People's Hospital of Hangzhou 47
Next Page